Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors ; volume:24 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer cell international ; 24, Heft 1 (10.9.2024), 1-13, 12.2024
- Creator
-
Chen, Yi-Chao
Zheng, Wei-Zhong
Liu, Chun-Peng
Zhao, Yong-Qiang
Li, Jun-Wei
Du, Ze-Sen
Zhai, Tian-Tian
Lin, Hao-Yu
Shi, Wen-Qi
Cai, Shan-Qing
Pan, Feng
Qiu, Si-Qi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03496-x
- URN
-
urn:nbn:de:101:1-2411242123441.521066442970
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Yi-Chao
- Zheng, Wei-Zhong
- Liu, Chun-Peng
- Zhao, Yong-Qiang
- Li, Jun-Wei
- Du, Ze-Sen
- Zhai, Tian-Tian
- Lin, Hao-Yu
- Shi, Wen-Qi
- Cai, Shan-Qing
- Pan, Feng
- Qiu, Si-Qi
- SpringerLink (Online service)
Other Objects (12)
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations